These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12194639)

  • 21. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.
    Ljung T; Lundberg S; Varsanyi M; Johansson C; Schmidt PT; Herulf M; Lundberg JO; Hellstrom PM
    World J Gastroenterol; 2006 Jun; 12(21):3386-92. PubMed ID: 16733856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
    Zhang W; Teng GG; Tian Y; Wang HH
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial function and cardiovascular risk in active inflammatory bowel diseases.
    Principi M; Mastrolonardo M; Scicchitano P; Gesualdo M; Sassara M; Guida P; Bucci A; Zito A; Caputo P; Albano F; Ierardi E; Di Leo A; Ciccone MM
    J Crohns Colitis; 2013 Nov; 7(10):e427-33. PubMed ID: 23473915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of measurement of exhaled nitric oxide in asthma patients].
    Zietkowski Z; Bodzenta-Lukaszyk A; Tomasiak MM; Skiepko R
    Pol Arch Med Wewn; 2005 Jan; 113(1):35-41. PubMed ID: 16130599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
    De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
    Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
    Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
    Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
    Kucharzik T; Stoll R; Lügering N; Domschke W
    Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.